Loading...
XTSECRRX
Market cap94mUSD
Jan 08, Last price  
2.19CAD
1D
1.86%
1Q
0.46%
Jan 2017
-81.44%
Name

CareRx Corp

Chart & Performance

D1W1MN
XTSE:CRRX chart
P/E
—
P/S
0.37
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
41.30%
Rev. gr., 5y
24.54%
Revenues
371m
-2.88%
7,142,3779,420,98812,321,11614,251,04515,795,22636,623,00062,482,000200,992,000436,651,000455,864,000308,074,000162,421,000167,363,000168,967,000123,742,000124,626,000162,196,000262,630,000381,727,000370,746,000
Net income
-5m
L-84.27%
130,611-348,08849,468754,686952,1861,640,0004,328,000-8,982,000-7,258,000-91,091,000-57,447,00046,083,000-19,677,0001,846,000-31,093,000-45,677,000-18,183,000-22,730,000-34,353,000-5,405,000
CFO
27m
+22.58%
851,65667,94286,696915,891433,2623,031,0005,945,0007,598,00015,314,00020,204,00019,719,00029,447,0001,700,00016,073,0006,592,0006,355,000229,0007,269,00022,333,00027,375,000
Earnings
Mar 05, 2025

Profile

CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
URL
https://www.carerx.ca/
IPO date
Sep 04, 2002
Employees
1,444
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
370,746
-2.88%
381,727
45.35%
Cost of revenue
363,520
306,225
Unusual Expense (Income)
NOPBT
7,226
75,502
NOPBT Margin
1.95%
19.78%
Operating Taxes
(4,190)
(1,543)
Tax Rate
NOPAT
11,416
77,045
Net income
(5,405)
-84.27%
(34,353)
51.14%
Dividends
Dividend yield
Proceeds from repurchase of equity
14,623
1,007
BB yield
-15.84%
-0.83%
Debt
Debt current
12,720
10,006
Long-term debt
115,938
153,662
Deferred revenue
3,233
Other long-term liabilities
2,774
3,727
Net debt
121,629
135,297
Cash flow
Cash from operating activities
27,375
22,333
CAPEX
(4,728)
(13,613)
Cash from investing activities
(12,314)
(16,598)
Cash from financing activities
(36,403)
(12,989)
FCF
9,136
64,492
Balance
Cash
7,029
28,371
Long term investments
Excess cash
9,285
Stockholders' equity
47,906
29,959
Invested Capital
182,289
197,356
ROIC
6.01%
38.74%
ROCE
3.96%
35.84%
EV
Common stock shares outstanding
57,350
47,596
Price
1.61
-37.11%
2.56
-55.01%
Market cap
92,333
-24.22%
121,846
-38.57%
EV
213,962
257,143
EBITDA
27,202
95,567
EV/EBITDA
7.87
2.69
Interest
14,270
15,221
Interest/NOPBT
197.48%
20.16%